Linezolid Resistance in Staphylococci.

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Linezolid is a crucial antibiotic for treating infections caused by Gram-positive pathogens, including multidrug-resistant strains like MRSA and VRE.
• It is frequently used for complicated infections when other treatments fail, demonstrating efficacy in conditions such as endocarditis, osteomyelitis, and tuberculosis.

Approach:

• Investigated the mechanisms of linezolid resistance in Gram-positive cocci, primarily focusing on mutations in 23S rRNA genes and ribosomal proteins.
• Identified a novel RNA methyltransferase, Cfr, conferring resistance to multiple antibiotic classes, including oxazolidinones, phenicols, and lincosamides.

Key Points:

• Linezolid resistance, while rare, is associated with specific nucleotide substitutions in 23S rRNA genes, influenced by drug exposure.
• The Cfr enzyme confers a broad resistance phenotype, distinct from previously known resistance mechanisms like erm methyltransferases.
• Emerging resistance necessitates the development of novel therapeutic agents.

Conclusions:

• Continued research into novel oxazolidinone derivatives with improved characteristics is essential to combat evolving antibiotic resistance.
• Several new oxazolidinone compounds are in advanced stages of development, offering potential alternatives to linezolid.